Skip to main content

Table 3 Multivariable OLS linear regressions for each SUTAQ domain

From: Patient characteristics associated with the acceptability of teleconsultation: a retrospective study of osteoporotic patients post-COVID-19

 

Perceived benefits

Satisfaction

Substitution

Care personnel concerns

Privacy and discomfort

ß (95% CI)

ß (95% CI)

ß (95% CI)

ß (95% CI)

ß (95% CI)

Demographics

 Gender

  Female

1.00

1.00

1.00

1.00

1.00

  Male

0.18 (-0.56—0.91)

0.21 (-0.35—0.76)

0.6 (-0.23—1.43)

-0.41 (-1.09—0.26)

-0.50* (-1.03—0.04)

 Age in years

  < 50

0.09 (-1.53—1.72)

-0.01 (-1.24—1.23)

-0.02 (-1.86—1.83)

0.1 (-1.39—1.60)

-0.46 (-1.65—0.73)

  50–64

0.24 (-0.65—1.12)

0.03 (-0.64—0.70)

0.35 (-0.65—1.35)

-0.15 (-0.96—0.66)

-0.39 (-1.03—0.26)

  65–74

1.00

1.00

1.00

1.00

1.00

  75 + 

-0.2 (-1.03—0.62)

-0.09 (-0.71—0.54)

-0.21 (-1.15—0.72)

-0.27 (-1.02—0.49)

0.01 (-0.60—0.61)

Socio-economic conditions

 Employment status

  Employed

1.00

1.00

1.00

1.00

1.00

  Retired

0.22 (-0.64—1.09)

0.08 (-0.58—0.74)

0.17 (-0.81—1.15)

-0.15 (-0.94—0.65)

-0.54* (-1.17—0.10)

  Unemployed

0.52 (-0.68—1.73)

0.47 (-0.45—1.38)

0.48 (-0.88—1.85)

-0.99* (-2.10—0.12)

-0.27 (-1.16—0.61)

 Education

  Low

1.00

1.00

1.00

1.00

1.00

  Intermediate

0.35 (-0.37—1.08)

0.26 (-0.29—0.81)

0.22 (-0.60—1.05)

-0.25 (-0.92—0.42)

-0.15 (-0.69—0.38)

  High

0.44 (-0.34—1.22)

0.38 (-0.22—0.97)

0.17 (-0.71—1.05)

-0.29 (-1.00—0.43)

-0.15 (-0.72—0.42)

Clinical characteristics

 Charlson comorbidity index

0.03 (-0.08—0.14)

-0.02 (-0.11—0.06)

0.02 (-0.11—0.15)

0.01 (-0.10—0.11)

0.03 (-0.05—0.11)

 History of bone fractures

  Never had

1.00

1.00

1.00

1.00

1.00

  Had fractures

0.1 (-0.63—0.83)

0.41 (-0.15—0.96)

-0.02 (-0.84—0.81)

0.19 (-0.48—0.86)

-0.11 (-0.65—0.42)

 Fractures during observation period

  No

1.00

1.00

1.00

1.00

1.00

  Yes

0.11 (-0.61—0.82)

0.22 (-0.32—0.76)

0.51 (-0.30—1.32)

-0.45 (-1.11—0.20)

-0.18 (-0.71—0.34)

 Years since osteoporosis diagnosis

0.04 (-0.01—0.09)

0.02 (-0.02—0.06)

0.04 (-0.01—0.10)

-0.02 (-0.06—0.03)

0 (-0.04—0.04)

    Total length of pharmacological treatment for osteoporosis (years)

-0.05 (-0.12—0.01)

-0.04* (-0.10—0.01)

-0.09** (-0.17—-0.01)

0.06* (-0.00—0.12)

0.02 (-0.03—0.07)

 Anti-osteoporosis treatment

  Teriparatide

1.00

1.00

1.00

1.00

1.00

  Denosumab

-0.24 (-0.90—0.42)

-0.38 (-0.88—0.12)

-0.4 (-1.15—0.35)

0.37 (-0.24—0.97)

-0.01 (-0.50—0.47)

  Oral bisphosphonate

-0.22 (-1.22—0.77)

0.07 (-0.69—0.83)

0.43 (-0.70—1.56)

0.11 (-0.81—1.02)

-0.16 (-0.89—0.58)

  Zolendronic acid

-0.08 (-1.34—1.17)

0.18 (-0.78—1.13)

0.04 (-1.39—1.46)

0.16 (-0.99—1.32)

0.15 (-0.77—1.07)

Pattern of TC use

 Date of first TC

  June 2020-March 2021

1.00

1.00

1.00

1.00

1.00

  April-November 2021

0.11 (-0.53—0.76)

0.41 (-0.08—0.90)

0.36 (-0.37—1.09)

-0.17 (-0.76—0.42)

-0.01 (-0.48—0.46)

 Switch to TC from in-person visits

  No

1.00

1.00

1.00

1.00

1.00

  Yes

-0.07 (-0.66—0.52)

-0.13 (-0.58—0.32)

0.06 (-0.60—0.73)

0.05 (-0.49—0.59)

-0.06 (-0.49—0.37)

 N. TCs before enrolment in study

0.12 (-0.17—0.40)

0.22** (0.00—0.43)

0.08 (-0.24—0.40)

-0.06 (-0.32—0.20)

-0.12 (-0.33—0.08)

 Face to face visits during TC

  No

1.00

1.00

1.00

1.00

1.00

  Yes

-0.04 (-0.69—0.62)

-0.27 (-0.77—0.23)

-0.41 (-1.16—0.33)

0.14 (-0.46—0.75)

0.34 (-0.14—0.83)

 Face to face visits during TC due patient’s request

  No

1.00

1.00

1.00

1.00

1.00

  Yes

0.07 (-0.88—1.02)

0.48 (-0.25—1.21)

0.14 (-0.94—1.22)

-0.05 (-0.93—0.82)

-0.21 (-0.91—0.49)

 Use of TC for other chronic conditions

  No

1.00

1.00

1.00

1.00

1.00

  Yes

-0.37 (-1.25—0.50)

-0.53 (-1.20—0.13)

-0.19 (-1.18—0.81)

0.17 (-0.63—0.98)

0.27 (-0.38—0.91)

Digital skills and social support

 Social support in operating TC platform

  No

1.00

1.00

1.00

1.00

1.00

  Yes

-0.02 (-0.73—0.69)

-0.22 (-0.76—0.32)

-0.27 (-1.08—0.53)

0.26 (-0.39—0.91)

-0.22 (-0.74—0.30)

 Digital skills

  Excellent/good

1.00

1.00

1.00

1.00

1.00

  Mediocre

0.19 (-0.54—0.93)

0.33 (-0.23—0.88)

0.17 (-0.66—1.00)

0.04 (-0.63—0.71)

0.3 (-0.23—0.84)

  Very poor

0.39 (-0.85—1.63)

0.69 (-0.25—1.63)

0.49 (-0.91—1.90)

-0.4 (-1.54—0.74)

-0.01 (-0.92—0.90)

  1. Legend: Significant results in bold; *** p < 0.01, ** p < 0.05, * p < 0.1